TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 25 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $178,000 | -91.3% | 76,048 | -98.3% | 0.44% | -90.4% |
Q3 2019 | $2,057,000 | -34.3% | 4,601,768 | 0.0% | 4.59% | +49.8% |
Q2 2019 | $3,129,000 | -50.4% | 4,601,768 | 0.0% | 3.06% | -40.3% |
Q1 2019 | $6,304,000 | +117.5% | 4,601,768 | 0.0% | 5.13% | +55.0% |
Q4 2018 | $2,899,000 | -69.3% | 4,601,768 | 0.0% | 3.31% | -49.8% |
Q3 2018 | $9,434,000 | -24.1% | 4,601,768 | 0.0% | 6.58% | -29.5% |
Q2 2018 | $12,425,000 | +60.6% | 4,601,768 | +36.8% | 9.34% | +40.1% |
Q1 2018 | $7,735,000 | – | 3,362,831 | – | 6.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Puissance Capital Management LP | 76,048 | $178,000 | 0.44% |
NEA Management Company, LLC | 346,718 | $811,000 | 0.04% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |